We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 10,000 results
  1. Discrete Choice Experiments to Elicit Patient Preferences for the Treatment of Major Depressive Disorder: A Systematic Review

    Background

    Individual preferences for treatment options for major depressive disorder can impact therapeutic decision making, adherence, and...

    Susan dosReis, Dafne Espinal Pena, ... Alejandro Amill-Rosario in The Patient - Patient-Centered Outcomes Research
    Article 05 July 2024
  2. Measuring the Direct Medical Costs of Hospital-Onset Infections Using an Analogy Costing Framework

    Background

    The majority of recent estimates on the direct medical cost attributable to hospital-onset infections (HOIs) has focused on device- or...

    R. Douglas Scott II, Steven D. Culler, ... Philip R. Wandschneider in PharmacoEconomics
    Article Open access 05 July 2024
  3. Are Medical Device Characteristics Included in HTA Methods Guidelines and Reports? A Brief Review

    It is well accepted that medical devices (MDs) and procedures have several unique characteristics compared with pharmaceuticals, such as learning...

    Rituparna Basu, Simon Eggington, ... Liesl Strachan in Applied Health Economics and Health Policy
    Article 04 July 2024
  4. A Cost-Effectiveness Analysis of Adjuvant Nivolumab for Patients with Resected Esophageal Cancer or Gastroesophageal Junction Cancer in France

    Introduction

    Esophageal and gastroesophageal junction cancer (EC/GEJC) is a poor prognosis disease with a high risk of recurrence even in patients...

    Paul Casabianca, Marc Massetti, ... Henri Leleu in PharmacoEconomics - Open
    Article Open access 04 July 2024
  5. Cost-benefit analysis of haemodialysis in patients with end-stage kidney disease in Abuja, Nigeria

    Background

    Significant gaps in scholarship on the cost-benefit analysis of haemodialysis exist in low-middle-income countries, including Nigeria. The...

    Yakubu Adole Agada-Amade, Daniel Chukwuemeka Ogbuabor, ... Obinna Emmanuel Onwujekwe in Health Economics Review
    Article Open access 03 July 2024
  6. Evaluating the Public Health and Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for Influenza Pandemic Control in China: A Cost-Effectiveness Analysis Using a Linked Dynamic Transmission–Economic Evaluation Model

    Background

    Pandemic influenza poses a recurring threat to public health. Antiviral drugs are vital in combating influenza pandemics. Baloxavir...

    Yawen Jiang, Jiaxin Wen, ... Yuelong Shu in PharmacoEconomics
    Article 03 July 2024
  7. Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia

    Introduction

    Immunocompromised host pneumonia (ICHP) is an important cause of morbidity and mortality, yet usual care (UC) diagnostic tests often fail...

    Andrew J. Sutton, Daniel S. Lupu, ... Bradley A. Perkins in PharmacoEconomics
    Article Open access 02 July 2024
  8. Estimating an EQ-5D-Y-3L Value Set for Brazil

    Introduction

    The EQ-5D-Y-3L is a generic measure of health-related quality of life in children and adolescents. Although the Brazilian-Portuguese...

    Caique Melo Espirito Santo, Gisela Cristiane Miyamoto, ... Tiê Parma Yamato in PharmacoEconomics
    Article Open access 02 July 2024
  9. Comparison of Two Financial Incentives to Encourage the Use of Adalimumab Biosimilars: Results of a French Experiment Close to Clinicians

    Background

    In 2018, the French government introduced two mutually exclusive financial incentives to increase etanercept and insulin glargine...

    Marion Tano, Pascal Paubel, ... Albane Degrassat-Théas in PharmacoEconomics - Open
    Article Open access 02 July 2024
  10. Net costs of breast cancer in Colombia: a cost-of-illness study based on administrative claims databases

    Background

    Breast Cancer (BC) is associated with substantial costs of healthcare; however, real-world data regarding these costs in Colombia is...

    Gabriel Fernando Torres, Brigitte Alejandra Alarcón, ... Giancarlo Buitrago in Cost Effectiveness and Resource Allocation
    Article Open access 02 July 2024
  11. Cost and Quality of Life of Disability Progression in Multiple Sclerosis Beyond EDSS: Impact of Cognition, Fatigue, and Limb Impairment

    Background and Objective

    Understanding the socioeconomic burden of multiple sclerosis (MS) is essential to inform policymakers and payers. Real-world...

    Jürgen Wasem, Yanic Heer, ... Paul Dillon in PharmacoEconomics - Open
    Article Open access 01 July 2024
  12. A Cost Evaluation of COVID-19 Remote Home Monitoring Services in England

    Background

    Remote home monitoring services emerged as critical components of health care delivery from NHS England during the COVID-19 pandemic,...

    Sonila M. Tomini, Efthalia Massou, ... Stephen Morris in PharmacoEconomics - Open
    Article Open access 01 July 2024
  13. Cost-Utility Analysis of TNF-α Inhibitors, B Cell Inhibitors, and JAK Inhibitors Versus csDMARDs for Rheumatoid Arthritis Treatment

    Introduction

    Rheumatoid arthritis (RA) is a progressive and debilitating disease, causing persistent joint pain that limits daily activities requiring...

    Madhumitha Haridoss, Akhil Sasidharan, ... Bhavani Shankara Bagepally in Applied Health Economics and Health Policy
    Article 01 July 2024
  14. A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial

    Background/Objectives

    Remote patient monitoring (RPM) has demonstrated numerous benefits in cancer care, including improved quality of life, overall...

    Etienne Minvielle, Henri Leleu, ... Florian Scotté in The European Journal of Health Economics
    Article 28 June 2024
  15. Short-Term Neurologic Complications in Patients Undergoing Extracorporeal Membrane Oxygenation Support: A Review on Pathophysiology, Incidence, Risk Factors, and Outcomes

    Regardless of the type, extracorporeal membrane oxygenation (ECMO) requires the use of large intravascular cannulas and results in multiple...

    Dominic V. Pisano, Jamel P. Ortoleva, Patrick M. Wieruszewski in Pulmonary Therapy
    Article Open access 28 June 2024
  16. Exploring unmet healthcare needs and associated inequalities among middle-aged and older adults in Eastern China during the progression toward universal health coverage

    Background

    Given the rapid population aging in China, achieving universal health coverage (UHC) presents a primary challenge in addressing unmet...

    Yunhan Wang, Nan Jiang, ... Zhonghua Wang in Health Economics Review
    Article Open access 27 June 2024
  17. Retrospective analysis of hospitalization costs using two payment systems: the diagnosis related groups (DRG) and the Queralt system, a newly developed case-mix tool for hospitalized patients

    Background

    Hospital services are typically reimbursed using case-mix tools that group patients according to diagnoses and procedures. We recently...

    Júlia Folguera, Elisabet Buj, ... Miquel Arrufat in Health Economics Review
    Article Open access 26 June 2024
  18. Estimating Risk Factor Time Paths Among People with Type 2 Diabetes and QALY Gains from Risk Factor Management

    Objectives

    Most type 2 diabetes simulation models utilise equations map** out lifetime trajectories of risk factors [e.g. glycated haemoglobin (HbA 1c...

    Ni Gao, Helen A. Dakin, ... Philip Clarke in PharmacoEconomics
    Article Open access 26 June 2024
  19. Valuating the efficiency of social security and healthcare in OECD countries from a sustainable development

    Under the goal of sustainable development, co** with the increase in social security and healthcare expenses caused by population aging is becoming...

    Li-wen Lee, Yung-ho Chiu, ... Tzu-Han Chang in Cost Effectiveness and Resource Allocation
    Article Open access 26 June 2024
Did you find what you were looking for? Share feedback.